Literature DB >> 12954911

Psychosomatic factors in first-onset alopecia areata.

A Picardi1, P Pasquini, M S Cattaruzza, P Gaetano, G Baliva, C F Melchi, M Papi, D Camaioni, A Tiago, T Gobello, M Biondi.   

Abstract

Although the onset of alopecia areata has often been anecdotally linked with emotional stress, findings from the few controlled studies have not been univocal. The authors compared outpatients experiencing a recent onset of alopecia areata (N=21) with outpatients affected by skin conditions commonly believed as having a low psychosomatic component (N=102). Participants were administered Paykel's Interview for Recent Life Events, the Experiences in Close Relationships scale, the 20-item Toronto Alexithymia Scale, and the Multidimensional Scale of Perceived Social Support. Multiple logistic regression was used to control for age and gender. The total number of recent life events (last 12 months) was not different between the alopecia patients and the comparison subjects. Also, the alopecia patients and the comparison subjects did not differ in terms of the number of undesirable or major events. The comparison subjects even experienced a greater number of uncontrollable events. Alopecia areata tended to be associated with high avoidance in attachment relationships, high alexithymic characteristics, and poor social support. The results suggest that personality characteristics might modulate individual susceptibility to alopecia areata.

Entities:  

Mesh:

Year:  2003        PMID: 12954911     DOI: 10.1176/appi.psy.44.5.374

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  18 in total

1.  Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model.

Authors:  Xingqi Zhang; Mei Yu; Wayne Yu; Joanne Weinberg; Jerry Shapiro; Kevin J McElwee
Journal:  J Invest Dermatol       Date:  2008-11-20       Impact factor: 8.551

2.  Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study.

Authors:  Hsing-Ying Ho; Chih-Kai Wong; Szu-Yuan Wu; Ray C Hsiao; Yi-Lung Chen; Cheng-Fang Yen
Journal:  Int J Environ Res Public Health       Date:  2021-02-01       Impact factor: 3.390

3.  Hyposecretion of the Adrenal Androgen Dehydroepiandrosterone Sulfate (DHEA-S) in the Majority of the Alopecia Areata Patients: Is it a Primitive and Pathogenic Perturbation of Hypothalamic-Pituitary-Adrenal Axis?

Authors:  Roberto d'Ovidio; Francesco Domenico d'Ovidio
Journal:  Int J Trichology       Date:  2011-01

4.  Alexithymia and acne vulgaris: a case control study.

Authors:  Didem Sunay; Murat Baykir; Gülfem Ateş; Meral Ekşioğlu
Journal:  Psychiatry Investig       Date:  2011-11-03       Impact factor: 2.505

5.  Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.

Authors:  Atrin Toussi; Virginia R Barton; Stephanie T Le; Oma N Agbai; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-06-17       Impact factor: 15.487

Review 6.  Brain-skin connection: stress, inflammation and skin aging.

Authors:  Ying Chen; John Lyga
Journal:  Inflamm Allergy Drug Targets       Date:  2014

7.  'Ho-ver'ing Over Alopecia Areata: Histopathological Study of 50 Cases.

Authors:  Manjot Marwah; Nitin Nadkarni; Sharmila Patil
Journal:  Int J Trichology       Date:  2014-01

8.  Prevalence of psychological disorders in patients with alopecia areata in comparison with normal subjects.

Authors:  Shahin Aghaei; Nasrin Saki; Ehsan Daneshmand; Bahare Kardeh
Journal:  ISRN Dermatol       Date:  2014-03-09

9.  Psychiatric morbidity and quality of life in vitiligo patients.

Authors:  Podaralla Ramakrishna; Tenali Rajni
Journal:  Indian J Psychol Med       Date:  2014-07

10.  The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study.

Authors:  Rim Sellami; J Masmoudi; U Ouali; L Mnif; M Amouri; H Turki; A Jaoua
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.